Results 121 to 130 of about 312,011 (322)

The COVID-19 vaccination

open access: yesMedicina Clínica (English Edition), 2021
Casas, Irma, Mena, Guillermo
openaire   +4 more sources

Research Progress in Wearable Microneedle Sensors for Health Analysis

open access: yesAdvanced Sensor Research, EarlyView.
Wearable biosensors are transforming personal healthcare by enabling minimally invasive, molecular‐level monitoring. Emerging electrochemical microneedle sensors can detect analytes in interstitial fluid, enabling painless extraction and real‐time tracking.
Adnan Zameer   +3 more
wiley   +1 more source

Antibody Response to COVID-19 mRNA Vaccine in Patients With Lung Cancer After Primary Immunization and Booster: Reactivity to the SARS-CoV-2 WT Virus and Omicron Variant

open access: green, 2022
Rajesh M. Valanparambil   +38 more
openalex   +2 more sources

A Systemic Selective Modified mRNA Delivery Platform for Preventing Chemotherapy‐Induced Cardiotoxicity

open access: yesAdvanced Science, EarlyView.
In Yoo and Mainkar et al., we present a minimally invasive, CM‐selective modRNA delivery system encapsulated in lipid nanoparticles for intravenous (IV) administration. This platform enables selective cardiac translation of therapeutic modRNA but suppresses expression in off‐target tissues, including tumors.
Jimeen Yoo   +19 more
wiley   +1 more source

COVID-19 Vaccines: Pharmacy Student Virtual Education Outreach Increases Knowledge and Vaccine Willingness among a College Campus Community [PDF]

open access: diamond, 2022
Fever Lacy La   +5 more
openalex   +1 more source

Potent and Long‐Lasting Immunogenicity Generated by LNP‐mRNA gE Antigen Against Varicella Zoster Virus via an AI‐Assisted Pipeline

open access: yesAdvanced Science, EarlyView.
This study designs a novel mRNA‐LNP vaccine targeting VZV glycoprotein E (gE) for herpes zoster via an AI‐assisted pipeline. Validated in mice and rhesus macaques, the mRNA‐LNP vaccine shows strong humoral and cellular immune responses, with CD4+ T‐cell responses more effective and durable than Shingrix, offering a promising prophylactic option ...
Kai Dong   +6 more
wiley   +1 more source

Exploring reasons for COVID-19 vaccine hesitancy among healthcare providers in Ethiopia

open access: gold, 2021
Fisseha Shiferie   +4 more
openalex   +1 more source

Home - About - Disclaimer - Privacy